Open AccessA combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
Author(s) -
Yasin Toklu,
Hasan Basri Çakmak,
Mücella Arıkan Yorgun,
Şule Berk Ergun,
Şaban Şimşek
Publication year - 2012
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1101-1470
Subject(s) - verteporfin , medicine , ranibizumab , photodynamic therapy , ophthalmology , visual acuity , serous fluid , fluorescein angiography , fundus (uterus) , combination therapy , choroidal neovascularization , surgery , chemotherapy , bevacizumab , organic chemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom